Date: September 07, 2022
Time: 10:00 am (PDT), 1:00 pm (EDT), 7:00 pm (CEST)
Severe acute respiratory syndrome coronavirus (SARS-CoV-2), the infection that causes COVID-19, is especially severe in older populations. The development of SARS-CoV-2 vaccines has helped advance a resolution to the COVID-19 pandemic but their efficacy is partly compromised by the recent emergence of variants with enhanced transmissibility. The emergence of these variants emphasizes the need for further development of anti-SARS-CoV-2 therapies, especially in aged populations.
- How to use murine SARS-CoV-2 infection models to study COVID-19 pathogenesis
- Understand the role of PLA2G2D, a phospholipase, and its downstream lipid product, prostaglandin D2 (PGD2) in the pathogenesis of SARS-CoV-2 infection
- Explore the potential of PLA2G2D-PGD2/PTGDR pathway-targeting COVID-19 therapies by using Asapiprant, a PTGDR antagonist
Webinars will be available for unlimited on-demand viewing after live event.